Publications

  1. Gothot RA, Maniaci MJ, Paulson MR, Dumic I, Haney AA, Li Z, Maita KC, Valles BT, Burger CD. Clinical Characteristics and Outcomes of Patients With COVID-19 Treated in Mayo Clinic's Advanced Care at Home Program. J Patient Saf. 2024 Dec 1; 20 (8):605-611
    View PubMed
  2. Burger CD, Saunders H, Hodge DO, Safford RE, Helgeson SA, Moss JE, DuBrock HM, Cartin-Ceba R, Cajigas HR, Krowka MJ. Echocardiography Screening of Consecutive Patients With Portal Hypertension Referred to Mayo Clinic for Liver Transplant Evaluation. Mayo Clin Proc. 2024 Nov 7 Epub 2024 Nov 07
    View PubMed
  3. O'Horo JC, Challener DW, Kudrna C, Buckmeier JR, Peters SG, Kor DJ, Matson MW, Badley AD, Burger CD, Chaudhry R. Leveraging real-time patient data during the COVID-19 pandemic. Infect Control Hosp Epidemiol. 2024 Oct 8; 1-2 Epub 2024 Oct 08
    View PubMed
  4. Koirala T, Burger CD, Chaudhry R, Benitez P, Heaton HA, Gopikrishnan N, Helgeson SA. Impact of a Disease-Focused Electronic Health Record Dashboard on Clinical Staff Efficiency in Previsit Patient Review in an Ambulatory Pulmonary Hypertension Care Clinic. Appl Clin Inform. 2024 Oct; 15 (5):928-938 Epub 2024 Nov 06
    View PubMed
  5. Burger CD, Tang W, Tsang Y, Panjabi S. Early Addition of Selexipag to Double Therapy for Pulmonary Arterial Hypertension. JAMA Netw Open. 2024 Sep 3; 7 (9):e2434691 Epub 2024 Sept 03
    View PubMed
  6. Burger CD, Tang W, Tsang Y, Panjabi S. Impact of selexipag maintenance dose on persistence, adherence, and hospitalization in US patients with pulmonary arterial hypertension. Pulm Circ. 2024 Jul; 14 (3):e12415 Epub 2024 Aug 18
    View PubMed
  7. Williams C, Paulson N, Sweat J, Rutledge R, Paulson MR, Maniaci M, Burger CD. Individual- and Community-Level Predictors of Hospital-at-Home Outcomes. Popul Health Manag. 2024 Jun; 27 (3):168-173 Epub 2024 Mar 28
    View PubMed
  8. Del Valle KT, Krowka MJ, Schinstock CA, Nath KA, Burger CD, Reddy YN, Frantz RP, Prakash YS, DuBrock HM. Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study. Pulm Circ. 2024 Jan; 14 (1):e12341 Epub 2024 Feb 10
    View PubMed
  9. Burger CD, Tsang Y, Chivers M, Vekaria RV, Doad G, Atkins N, Panjabi S. Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review. Clinicoecon Outcomes Res. 2024; 16:447-459 Epub 2024 May 30
    View PubMed
  10. McEvoy C, Argula R, Sahay S, Shapiro S, Eagan C, Hickey AJ, Smutney C, Dillon C, Winkler T, Davis BN, Broderick M, Burger C. Tyvaso DPI: Drug-device characteristics and patient clinical considerations. Pulm Pharmacol Ther. 2023 Dec; 83:102266 Epub 2023 Nov 13
    View PubMed
  11. Morales-Lara AC, Elkhatib W, Oluleye O, Alhusain R, Saad A, Salwa N, Siddiqui H, Wieczorek MA, Ray J, Parikh P, Burger C, Shapiro B, Kusumoto F, Pillai D, Adedinsewo D. Impact of Pulmonary Hypertension Hemodynamic Phenotype on Incident Atrial Fibrillation. Cardiology. 2023; 148(4):353-362. Epub 2023 Jun 05.
    View PubMed
  12. Burger CD, Wu B, Classi P, Morland K. Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension. J Manag Care Spec Pharm. 2023 Jan; 29 (1):101-108
    View PubMed
  13. Cajigas HR, Burger CD, Cartin-Ceba R, DuBrock H, Swanson K, Vargas HE, Keaveny AP, Watt KD, Krowka M. Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry. Mayo Clin Proc. 2022 Dec; 97 (12):2236-2247 Epub 2022 Nov 03
    View PubMed
  14. DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ, PHAR Investigators. Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry. Pulm Circ. 2022 Oct; 12 (4):e12172 Epub 2022 Dec 15
    View PubMed
  15. Helgeson SA, Burger CD, Moss JE, Zeiger TK, Taylor BJ. Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed? Am J Respir Crit Care Med 2022 Sep 1; 206 (5):650-651
    View PubMed
  16. Rahaghi FF, Balasubramanian VP, Bourge RC, Burger CD, Chakinala MM, Eggert MS, Elwing JM, Feldman J, King C, Klinger JR, Mathai SC, McConnell JW, Palevsky HI, Restrepo-Jaramillo R, Safdar Z, Sager JS, Sood N, Sulica R, White RJ, Hill NS. Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat. Pulm Circ. 2022 Apr; 12 (2):e12055 Epub 2022 Apr 07
    View PubMed
  17. Spikes LA, Bajwa AA, Burger CD, Desai SV, Eggert MS, El-Kersh KA, Fisher MR, Johri S, Joly JM, Mehta J, Palevsky HI, Ramani GV, Restrepo-Jaramillo R, Sahay S, Shah TG, Deng C, Miceli M, Smith P, Shapiro SM. BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI in patients with pulmonary arterial hypertension. Pulm Circ. 2022 Apr; 12 (2):e12063 Epub 2022 Apr 07
    View PubMed
  18. Temesgen Z, Burger CD, Baker J, Polk C, Libertin CR, Kelley CF, Marconi VC, Orenstein R, Catterson VM, Aronstein WS, Durrant C, Chappell D, Ahmed O, Chappell G, Badley AD, LIVE-AIR Study Group. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. Lancet Respir Med. 2022 Mar; 10 (3):237-246 Epub 2021 Dec 01
    View PubMed
  19. Saunders H, Helgeson SA, Abdelrahim A, Rottman-Pietrzak K, Reams V, Zeiger TK, Moss JE, Burger CD. Comparing Diagnosis and Treatment of Pulmonary Hypertension Patients at a Pulmonary Hypertension Center versus Community Centers. Diseases. 2022 Jan 7; 10 (1) Epub 2022 Jan 07
    View PubMed
  20. Nyman MA, Jose T, Croghan IT, Parkulo MA, Burger CD, Schroeder DR, Hurt RT, O'Horo JC. Utilization of an Electronic Health Record Integrated Risk Score to Predict Hospitalization Among COVID-19 Patients. J Prim Care Community Health. 2022 Jan-Dec; 13:21501319211069748
    View PubMed
  21. Pati S, Thompson GE, Mull CJ, Allen DH, Fazio JR, Felix HM, Paulson M, Chaudhry R, Matcha GV, Maniaci MJ, Burger CD, Quest DJ. Improving Patient Selection and Prioritization for Hospital at Home Through Predictive Modeling. AMIA Annu Symp Proc. 2022; 2022:856-865. Epub 2023 Apr 29.
    View PubMed
  22. Burger CD, DuBrock HM, Cartin-Ceba R, Moss JE, Shapiro BP, Frantz RP. Topic-Based, Recent Literature Review on Pulmonary Hypertension. Mayo Clin Proc. 2021 Dec; 96 (12):3109-3121 Epub 2021 Aug 31
    View PubMed
  23. Helgeson SA, Burger CD, Moss JE, Zeiger TK, Taylor BJ. Facemasks and Walk Distance in Pulmonary Arterial Hypertension Patients. Mayo Clin Proc Innov Qual Outcomes. 2021 Oct; 5 (5):835-838 Epub 2021 Aug 25
    View PubMed
  24. Cartin-Ceba R, Burger C, Swanson K, Vargas H, Aqel B, Keaveny AP, Heimbach J, Taner T, Nyberg S, Rosen C, Cajigas H, DuBrock H, Krowka MJ. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension. Transplantation. 2021 Oct 1; 105 (10):2283-2290
    View PubMed
  25. Helgeson SA, Waddle MR, Burnside RC, Debella YT, Lee AS, Burger CD, Li Z, Johnson PW, Patel NM. Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer. South Med J. 2021 Sep; 114 (9):607-613
    View PubMed
  26. DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ. Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry. Pulm Circ. 2021 Jul-Sep; 11 (3):20458940211020913 Epub 2021 May 17
    View PubMed
  27. Lee JD, Burger CD, Rayner SG, Ryan JJ, Leary PJ. Reply: COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match? Ann Am Thorac Soc 2021 Jun; 18 (6):1081-1082
    View PubMed
  28. Kolaitis NA, Zamanian RT, de Jesus Perez VA, Badesch DB, Benza RL, Burger CD, Chakinala MM, Elwing JM, Feldman J, Lammi MR, Mathai SC, McConnell JW, Presberg KW, Robinson JC, Sager J, Shlobin OA, Simon MA, Kawut SM, Glidden DV, Singer JP, De Marco T, Pulmonary Hypertension Association Registry Investigators. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry. Ann Am Thorac Soc. 2021 Apr; 18 (4):613-622
    View PubMed
  29. O'Horo JC, Cerhan JR, Cahn EJ, Bauer PR, Temesgen Z, Ebbert J, Abril A, Abu Saleh OM, Assi M, Berbari EF, Bierle DM, Bosch W, Burger CD, Cano Cevallos EJ, Clements CM, Carmona Porquera EM, Castillo Almeida NE, Challener DW, Chesdachai S, Comba IY, Corsini Campioli CG, Crane SJ, Dababneh AS, Enzler MJ, Fadel HJ, Ganesh R, De Moraes AG, Go JR, Gordon JE, Gurram PR, Guru PK, Halverson EL, Harrison MF, Heaton HA, Hurt R, Kasten MJ, Lee AS, Levy ER, Libertin CR, Mallea JM, Marshall WF 3rd, Matcha G, Meehan AM, Franco PM, Morice WG 2nd, O'Brien JJ, Oeckler R, Ommen S, Oravec CP, Orenstein R, Ough NJ, Palraj R, Patel BM, Pureza VS, Pickering B, Phelan DM, Razonable RR, Rizza S, Sampathkumar P, Sanghavi DK, Sen A, Siegel JL, Singbartl K, Shah AS, Shweta F, Speicher LL, Suh G, Tabaja H Jr, Tande A, Ting HH, Tontz RC 3rd, Vaillant JJ, Vergidis P, Warsame MY, Yetmar ZA, Zomok CCD, Williams AW, Badley AD. Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 Mar; 96 (3):601-618 Epub 2020 Dec 26
    View PubMed
  30. Jose T, Warner DO, O'Horo JC, Peters SG, Chaudhry R, Binnicker MJ, Burger CD. Digital Health Surveillance Strategies for Management of Coronavirus Disease 2019. Mayo Clin Proc Innov Qual Outcomes. 2021 Feb; 5 (1):109-117 Epub 2020 Dec 14
    View PubMed
  31. Lee JD, Burger CD, Delossantos GB, Grinnan D, Ralph DD, Rayner SG, Ryan JJ, Safdar Z, Ventetuolo CE, Zamanian RT, Leary PJ. A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care. Ann Am Thorac Soc. 2020 Dec; 17 (12):1576-1582
    View PubMed
  32. DuBrock HM, Runo JR, Sadd CJ, Burger CD, Cartin-Ceba R, Rosen CB, Taner T, Nyberg SL, Heimbach JK, Findlay JY, Krowka MJ. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure >/=35 mm Hg. Transplant Direct. 2020 Dec; 6 (12):e630 Epub 2020 Nov 10
    View PubMed
  33. Temesgen Z, Assi M, Shweta FNU, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Palraj R, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley AD. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 Nov; 95 (11):2382-2394 Epub 2020 Sept 03
    View PubMed
  34. Min J, Feng R, Badesch D, Berman-Rosenzweig E, Burger C, Chakinala M, De Marco T, Feldman J, Hemnes A, Horn EM, Lammi MR, Mathai S, McConnell JW, Presberg K, Robinson J, Sager J, Shlobin OA, Simon M, Thenappan T, Ventetuolo C, Al-Naamani N, PHAR Investigators. Obesity in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR). Ann Am Thorac Soc. 2020 Oct 21; 18 (2):229-37 [Epub ahead of print]
    View PubMed
  35. Sher T, Burger CD, DeMartino ES, de Moraes AG, Sharp RR. Resuscitation and COVID-19: Recalibrating Patient and Family Expectations During a Pandemic. Mayo Clin Proc. 2020 Sep; 95 (9):1848-1851 Epub 2020 June 29
    View PubMed
  36. Burger CD, Mikhail AE, Orenstein R, Ebbert JO, Vergidis P, Badley AD. Research Response to SARS-CoV-2/COVID-19. Mayo Clin Proc. 2020 Sep; 95 (9S):S52-S55 Epub 2020 July 07
    View PubMed
  37. Temesgen Z, Assi M, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Varatharaj Palraj BR, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley A. First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia. medRxiv 2020 Jun 14 Epub 2020 June 14
    View PubMed
  38. Helgeson SA, Menon D, Helmi H, Vadlamudi C, Moss JE, Zeiger TK, Burger CD. Psychosocial and Financial Burden of Therapy in USA Patients with Pulmonary Arterial Hypertension. Diseases. 2020 Jun 13; 8 (2) Epub 2020 June 13
    View PubMed
  39. Preston IR, Burger CD, Bartolome S, Safdar Z, Krowka M, Sood N, Ford HJ, Battarjee WF, Chakinala MM, Gomberg-Maitland M, Hill NS. Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial. J Heart Lung Transplant. 2020 May; 39 (5):464-472 Epub 2020 Jan 21
    View PubMed
  40. Ray JC, Burger C, Mergo P, Safford R, Blackshear J, Austin C, Fairweather D, Heckman MG, Zeiger T, Dubin M, Shapiro B. Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension. Int J Cardiovasc Imaging. 2019 Oct; 35 (10):1881-1892 Epub 2018 June 22
    View PubMed
  41. Helgeson SA, Enderby CY, Moss JE, Gass JM, Zeiger TK, Burger CD. Twelve-Year Survival in a Patient With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension on Nifedipine Monotherapy. Mayo Clin Proc Innov Qual Outcomes. 2019 Sep; 3 (3):376-379 Epub 2019 July 19
    View PubMed
  42. Benza RL, Gomberg-Maitland M, Elliott CG, Farber HW, Foreman AJ, Frost AE, McGoon MD, Pasta DJ, Selej M, Burger CD, Frantz RP. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies. Chest. 2019 Aug; 156 (2):323-337 Epub 2019 Feb 14
    View PubMed
  43. Ussavarungsi K, Laroia AT, Burger CD. Low-dose sirolimus in retroperitoneal lymphangioleiomyomas. Lung India. 2019 Jul-Aug; 36 (4):349-352
    View PubMed
  44. Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Tregouet DA, Prokopenko I, Kittles R, Graf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR, UK NIHR BioResource Rare Diseases Consortium//UK PAH Cohort Study Consortium//US PAH Biobank Consortium. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Lancet Respir Med. 2019 Mar; 7 (3):227-238 Epub 2018 Dec 05
    View PubMed
  45. Mira-Avendano I, Abril A, Burger CD, Dellaripa PF, Fischer A, Gotway MB, Lee AS, Lee JS, Matteson EL, Yi ES, Ryu JH. Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases. Mayo Clin Proc. 2019 Feb; 94 (2):309-325 Epub 2018 Dec 14
    View PubMed
  46. Enderby CY, Burger C. Tolerability and clinical efficacy of inhaled treprostinil in patients with group 1 pulmonary arterial hypertension. Ther Adv Chronic Dis. 2018 Sep; 9 (9):171-177 Epub 2018 June 03
    View PubMed
  47. Krencz I, Sebestyen A, Papay J, Jeney A, Hujber Z, Burger CD, Keller CA, Khoor A. In situ analysis of mTORC1/2 and cellular metabolism-related proteins in human Lymphangioleiomyomatosis. Hum Pathol. 2018 Sep; 79:199-207 Epub 2018 June 06
    View PubMed
  48. Burger CD, Ozbay AB, Lazarus HM, Riehle E, Montejano LB, Lenhart G, White RJ. Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States. J Manag Care Spec Pharm. 2018 Aug; 24 (8):834-842 Epub 2018 Feb 13
    View PubMed
  49. Helgeson SA, Imam JS, Moss JE, Hodge DO, Burger CD. Comparison of Brain Natriuretic Peptide Levels to Simultaneously Obtained Right Heart Hemodynamics in Stable Outpatients with Pulmonary Arterial Hypertension. Diseases. 2018 May 1; 6 (2) Epub 2018 May 01
    View PubMed
  50. Batton KA, Austin CO, Bruno KA, Burger CD, Shapiro BP, Fairweather D. Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease. Biol Sex Differ. 2018 Apr 18; 9 (1):15
    View PubMed
  51. Burger CD, Pruett JA, Lickert CA, Berger A, Murphy B, Drake W 3rd. Prostacyclin Use Among Patients with Pulmonary Arterial Hypertension in the United States: A Retrospective Analysis of a Large Health Care Claims Database. J Manag Care Spec Pharm. 2018 Mar; 24 (3):291-302 Epub 2017 Dec 18
    View PubMed
  52. McLaughlin V, Bacchetta M, Badesch D, Benza R, Burger C, Chin K, Frantz R, Frost A, Hemnes A, Kim NH, Rosenzweig EB, Rubin L. Update on pulmonary arterial hypertension research: proceedings from a meeting of experts. Curr Med Res Opin. 2018 Feb; 34 (2):263-273 Epub 2017 Dec 22
    View PubMed
  53. Díaz-Gómez JL, Ripoll JG, Mira-Avendano I, Moss JE, Divertie GD, Frank RD, Burger CD. Multidisciplinary Perioperative Management of Pulmonary Arterial Hypertension in Patients Undergoing Noncardiac Surgery. South Med J. 2018 Jan; 111(1):64-73.
    View PubMed
  54. Ussavarungsi K, Thomas CS, Burger CD. Prevalence of metabolic syndrome in patients with pulmonary hypertension. Clin Respir J. 2017 Nov; 11 (6):721-726 Epub 2015 Nov 09
    View PubMed
  55. Austin C, Burger C, Kane G, Safford R, Blackshear J, Ung R, Ray J, Alsaad A, Alassas K, Shapiro B. High-risk echocardiographic features predict mortality in pulmonary arterial hypertension. Am Heart J. 2017 Jul; 189:167-176.
    View PubMed
  56. Rahaghi FF, Alnuaimat HM, Awdish RLA, Balasubramanian VP, Bourge RC, Burger CD, Butler J, Cauthen CG, Chakinala MM, deBoisblanc BP, Eggert MS, Engel P, Feldman J, McConnell JW, Park M, Sager JS, Sood N, Palevsky HI. Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document. Pulm Circ. 2017 Jul-Sep; 7 (3):702-711 Epub 2017 Aug 22
    View PubMed
  57. Lu C, Lee HS, Pappas GP, Dilling DF, Burger CD, Shifren A, Veeraraghavan S, Chapman JT, Parambil J, Ruoss SJ, Young LR, Hammes SR, Kopras EJ, Roads T, Krischer JP, McCormack FX, Trial of an Aromatase Inhibitor in Lymphangioleiomyomatosis Group. A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis. Ann Am Thorac Soc. 2017 Jun; 14 (6):919-928
    View PubMed
  58. Levine Deborah, Vartevan Alysha, McComb Barbara. PH Grand Rounds: Chronic Thromboembolic Desease Cloaknig Unilateral Pulmonary Artery Hypoplasia Advances in Pulmonary Hypertension. 2017; 15(3).
  59. Bajwa AA, Shujaat A, Patel M, Thomas C, Rahaghi F, Burger CD. The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease. Pulm Circ. 2017 Mar; 7(1):82-88. Epub 2017 Feb 01.
    View PubMed
  60. Burger CD, Ghandour M, Padmanabhan Menon D, Helmi H, Benza RL. Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes. Clinicoecon Outcomes Res. 2017; 9:731-739 Epub 2017 Nov 24
    View PubMed
  61. Ussavarungsi K, Lee AS, Burger CD. Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension? Oman Med J. 2016 Sep; 31 (5):345-51
    View PubMed
  62. Zamanian RT, Levine DJ, Bourge RC, De Souza SA, Rosenzweig EB, Alnuaimat H, Burger C, Mathai SC, Leedom N, DeAngelis K, Lim A, De Marco T. An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertension. Pulm Circ. 2016 Sep; 6 (3):329-37
    View PubMed
  63. Burger CD, D'Albini L, Raspa S, Pruett JA. The evolution of prostacyclins in pulmonary arterial hypertension: from classical treatment to modern management. Am J Manag Care. 2016 Jan; 22: (1 Suppl)S3-15.
    View PubMed
  64. Pinkstaff SO, Burger CD, Daugherty J, Bond S, Arena R. Cardiopulmonary exercise testing in patients with pulmonary hypertension: clinical recommendations based on a review of the evidence. Expert Rev Respir Med. 2016; 10 (3):279-95 Epub 2016 Feb 06
    View PubMed
  65. Safford RE, Ray JC, Burger CD, Blackshear JL, Mergo PJ, Shapiro BP. Is cardiac magnetic resonance imaging underutilized in the diagnosis of pulmonary hypertension? Advances in Pulmonary Hypertension.2015;14:(2)102-4.
  66. Ussavarungsi K, Hu X, Scott JP, Erasmus DB, Mallea JM, Alvarez F, Lee AS, Keller CA, Ryu JH, Burger CD. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis. Respir Med. 2015 Oct; 109: (10)1354-9.
    View PubMed
  67. Ussavarungsi K, Lee AS, Burger CD. Mosaic Pattern of Lung Attenuation on Chest CT in Patients with Pulmonary Hypertension. Diseases. 2015 Sep 7; 3 (3):205-212 Epub 2015 Sept 07
    View PubMed
  68. Enderby CY, Burger C. Medical treatment update on pulmonary arterial hypertension. Ther Adv Chronic Dis. 2015 Sep; 6 (5):264-72
    View PubMed
  69. Zeiger T, Cobo GC, Dillingham C, Burger CD. Prevalence of Sodium and Fluid Restriction Recommendations for Patients with Pulmonary Hypertension. Healthcare (Basel). 2015 Jul 28; 3 (3):630-6 Epub 2015 July 28
    View PubMed
  70. Khatri V, Neal JE, Burger CD, Lee AS. Prognostication in Pulmonary Arterial Hypertension with Submaximal Exercise Testing. Diseases. 2015 Feb 6; 3 (1):15-23 Epub 2015 Feb 06
    View PubMed
  71. Austin C, Alassas K, Burger C, Safford R, Pagan R, Duello K, Kumar P, Zeiger T, Shapiro B. Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension. Chest. 2015 Jan; 147 (1):198-208
    View PubMed
  72. Ussavarungsi K, Kaplan J, Burger C, Arunthari V. Survey of restless legs syndrome in a pulmonary hypertension population. Clin Respir J. 2015 Jan; 9(1):98-103. Epub 2014 Feb 24.
    View PubMed
  73. Frantz RP, Durst L, Burger CD, Oudiz RJ, Bourge RC, Franco V, Waxman AB, McDevitt S, Walker S. Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study. J Cardiovasc Pharmacol Ther. 2014 Nov; 19(6):550-7. Epub 2014 Apr 17.
    View PubMed
  74. Burger CD, Long PK, Shah MR, McGoon MD, Miller DP, Romero AJ, Benton WW, Safford RE. Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry. Chest. 2014 Nov; 146 (5):1263-1273
    View PubMed
  75. Pagan RJ, Lee AS, Austin CO, Burger CD. Screening for connective tissue disease in pulmonary arterial hypertension. South Med J. 2014 Oct; 107(10):666-9.
    View PubMed
  76. Enderby CY, Soukup M, Al Omari M, Zeiger T, Burger C. Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series. J Clin Pharm Ther. 2014 Oct; 39 (5):496-500 Epub 2014 May 08
    View PubMed
  77. Neal JE, Lee AS, Burger CD. Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity. Clin Respir J. 2014 Oct; 8(4):404-9. Epub 2014 Jan 10.
    View PubMed
  78. Karnatovskaia LV, Matharu J, Burger C, Keller CA. Inhaled nitric oxide as a potential rescue therapy for persistent hepatopulmonary syndrome after liver transplantation. Transplantation 2014 Sep 27; 98 (6):e64-6
    View PubMed
  79. Preston IR, Feldman J, White J, Franco V, Ishizawar D, Burger C, Waxman AB, Hill NS. Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension. Pulm Circ. 2014 Sep; 4 (3):456-61
    View PubMed
  80. Ussavarungsi K, Burger CD. Pulmonary arterial hypertension in a patient with beta-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literature. Pulm Circ. 2014 Sep; 4 (3):520-6
    View PubMed
  81. Alassas K, Mergo P, Ibrahim el-S, Burger C, Safford R, Parikh P, Shapiro B. Cardiac MRI as a diagnostic tool in pulmonary hypertension. Future Cardiol. 2014 Jan; 10(1):117-30.
    View PubMed
  82. Snipelisky D, Burger C, Shapiro B, Kusumoto F. Electrocardiographic changes in patients responding to treatment with group I pulmonary arterial hypertension. South Med J. 2013 Nov; 106 (11):618-23
    View PubMed
  83. Freeman ML, Landolfo C, Safford RE, Keller CA, Heckman MG, Burger CD. Noninvasive assessment of right heart function and hemodynamics during exercise in patients with pulmonary arterial hypertension. South Med J. 2013 Feb; 106 (2):141-6
    View PubMed
  84. Duello KM, Louh IK, Burger CD. 48-Year-old woman with dyspnea, cough, and weight loss. Mayo Clin Proc. 2012 Nov; 87 (11):1124-7
    View PubMed
  85. Ryu JH, Sykes AM, Lee AS, Burger CD. Cystic lung disease is not uncommon in men with tuberous sclerosis complex. Respir Med. 2012 Nov; 106: (11)1586-90.
    View PubMed
  86. Vazquez AA, Aduen JF, Aduen P, Heckman MG, Burger CD. Should all patients with pulmonary hypertension undergo HIV serologic testing? South Med J. 2011 Aug; 104(8):589-92.
    View PubMed
  87. Burger CD, Foreman AJ, Miller DP, Safford RE, McGoon MD, Badesch DB. Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination Survey. Mayo Clin Proc. 2011 Feb; 86 (2):105-12
    View PubMed
  88. Aduen JF, Castello R, Daniels JT, Diaz JA, Safford RE, Heckman MG, Crook JE, Burger CD. Accuracy and precision of three echocardiographic methods for estimating mean pulmonary artery pressure. Chest. 2011 Feb; 139(2):347-352. Epub 2010 Jul 22.
    View PubMed
  89. Arunthari V, Burger CD, Lee AS. Correlation of pulmonary function variables with hemodynamic measurements in patients with pulmonary arterial hypertension. Clin Respir J. 2011 Jan; 5(1):35-43.
    View PubMed
  90. Patel NM, Burger CD. Two cases of stem cell therapy for pulmonary hypertension: A clinical report. Respiratory Medicine CME. 2011; 4(2):70-4.
  91. Arunthari V, Heckman MG, Burger CD. Prevalence of acute vasoresponsiveness in patients with pulmonary hypertension: treatment implications. South Med J. 2010 Jul; 103(7):630-4.
    View PubMed
  92. Burger CD, Zeiger T. What can be learned in 6 minutes? 6-minute walk test primer and role in pulmonary arterial hypertension. Advances in Pulmonary Hypertension. 2010:9:107-11.
  93. William WH, Safford RE, Heckman MG, Crook JE, Burger CD. Pulmonary arterial hypertension and obesity. Open Obesity J. 2010:2:132-36.
  94. Burger CD. Recent updates in the both the diagnosis and treatment options that impact the clinical treatment of pulmonary arterial hypertension. Clinical Medicine Insights: Therapeutics. 2010; 2:291-7.
  95. Aduen JF, Castello R, Lozano MM, Hepler GN, Keller CA, Alvarez F, Safford RE, Crook JE, Heckman MG, Burger CD. An alternative echocardiographic method to estimate mean pulmonary artery pressure: diagnostic and clinical implications. J Am Soc Echocardiogr. 2009 Jul; 22(7):814-9. Epub 2009 Jun 07.
    View PubMed
  96. Arunthari V, Burger CD. Utility of d-dimer in the diagnosis of patients with chronic thromboembolic pulmonary hypertension. Open Respir Med J. 2009 Jun 5; 3:85-9 Epub 2009 June 05
    View PubMed
  97. Burger CD. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators. COPD. 2009 Apr; 6(2):137-44.
    View PubMed
  98. Gisel JJ, Daniels JT, Burger CD. Clinical Utility of thyroperoxidase antibody testing in patients with pulmonary hypertension. Thyroid Science. 2009; 4:CLS1-5.
  99. Burger CD, Murali S. The vasoreactive patient: diagnosis, treatment and follow-up. Advances in Pulmonary Hypertension. 2008; 6:176-179.
  100. Li JH, Safford RE, Aduen JF, Heckman MG, Crook JE, Burger CD. Pulmonary hypertension and thyroid disease. Chest. 2007 Sep; 132(3):793-7. Epub 2007 Jul 23.
    View PubMed
  101. Burger CD. Utility of positive bronchoalveolar lavage in predicting respiratory failure after hematopoietic stem cell transplantation: a retrospective analysis. Transplant Proc. 2007 Jun; 39(5):1623-5.
    View PubMed
  102. Burger CD, Hampton KW, Sorensen CL, Diverti GD. The process and results of implementing the ventilator bundle to reduce ventilator-associated pneumonia rates. Respiratory Therapy. 2007; 2:23-25.
  103. Burger CD. "Multi-disciplinary rounds: a method to improve quality and safety of critically ill patients. Northeast Florida Medicine. 2007; 58:16-19.
  104. Bloomfield EL, Divertie GD, Burger CD, Larson JS, Brown DR, Patel BM, Rady MY, Johnson MM, Murray MJ. A comparison of intensive care unit physician staffing costs at the 3 Mayo Clinic sites. Mayo Clin Proc. 2006 Nov; 81(11):1457-61.
    View PubMed
  105. Tun HW, Wallace KH, Grinton SF, Khoor A, Burger CD. Etanercept therapy for late-onset idiopathic pneumonia syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation. Transplant Proc. 2005 Dec; 37(10):4492-6.
    View PubMed
  106. Yen KT, Putzke JD, Staats BA, Burger CD. The prevalence of acute response to bronchodilator in pulmonary lymphangioleiomyomatosis. Respirology. 2005 Nov; 10(5):643-8.
    View PubMed
  107. Aduen JF, Hellinger WC, Kramer DJ, Stapelfeldt WH, Bonatti H, Crook JE, Steers JL, Burger CD. Spectrum of pneumonia in the current era of liver transplantation and its effect on survival. Mayo Clin Proc. 2005 Oct; 80(10):1303-6.
    View PubMed
  108. Noh KW, McKinney JM, Burger CD, Bouras EP. Arterioportal fistula. Gastrointest Endosc. 2005 Aug; 62 (2):305; discussion 305
    View PubMed
  109. Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD. Acute mesenteric ischemia: a clinical review. Arch Intern Med. 2004 May 24; 164 (10):1054-62
    View PubMed
  110. Yen KT, Lee AS, Krowka MJ, Burger CD. Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment. Clin Chest Med. 2004 Mar; 25(1):189-201.
    View PubMed
  111. Aduen JF, Stapelfeldt WH, Johnson MM, Jolles HI, Grinton SF, Divertie GD, Burger CD. Clinical relevance of time of onset, duration, and type of pulmonary edema after liver transplantation. Liver Transpl. 2003 Jul; 9 (7):764-71
    View PubMed
  112. Ott MC, Khoor A, Leventhal JP, Paterick TE, Burger CD. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest. 2003 Feb; 123 (2):646-51
    View PubMed
  113. Yen KT, Krowka MJ, Lee AS, Kramer DJ, Burger CD. Liver and lung: how to manage portopulmonary hypertension: despite high pulmonary artery pressure, ECG findings may be normal. J Crit Illn. 2002 Oct; 17(10):401-6.
  114. Yen KT, Krowka MJ, Lee AS, Kramer DJ, Burger CD. Liver and lung: hepatopulmonary syndrome: recognizing the clinical features and selecting the right studies. J Crit Illn. 2002 Aug; 17(8):309-15.
  115. Scolapio JS, Savoy AD, Kaplan J, Burger CD, Lin SC. Sleep patterns of cyclic parenteral nutrition, a pilot study: are there sleepless nights? JPEN J Parenter Enteral Nutr. 2002 May-Jun; 26: (3)214-7.
    View PubMed
  116. Ott MC, Meschia JF, Mackey DC, Brodersen MP, Burger C, Echols JD, Fenton DS. Cerebral embolization presenting as delayed, severe obtundation in the postanesthesia care unit after total hip arthroplasty. Mayo Clin Proc. 2000 Nov; 75(11):1209-13.
    View PubMed
  117. Becker PM, Jamieson AO, Jewel CE, Bogan RK, James DS, Sutton JT, Corser B, Mayleben DW, Bernard SH, Dinner DS, Emsellem H, Knight E, Erwin CW, Krystal AD, Radtke RA, Farrow S, Odynski T, Pinto J, Steljes D, Feldman NT, O'Brien M, Fredrickson PA, Kaplan J, Lin SC, Burger C, Gross PT, et al. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology. 2000 Mar 14; 54(5):1166-1175.
    View PubMed
  118. Lin SC, Kaplan J, Burger CD, Fredrickson PA. Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc. 1998 Jun; 73 (6):497-500
    View PubMed
  119. Burger CD, Stanson AW, Daniels BK, Sheedy PF 2nd, Shepard JW Jr. Fast-computed tomographic evaluation of the effect of route of breathing on upper airway size and function in normal men. Chest. 1993 Apr; 103 (4):1032-7
    View PubMed
  120. Burger CD, Shepard JW Jr. Sleep-disordered breathing and aging. Lung Biol Health Dis. 1993; 63:61-80.
  121. Burger CD, Stanson AW, Daniels BK, Sheedy PF 2nd, Shepard JW Jr. Fast-CT evaluation of the effect of lung volume on upper airway size and function in normal men. Am Rev Respir Dis. 1992 Aug; 146: (2)335-9.
    View PubMed
  122. Burger CD, Stanson AW, Sheedy PF 2nd, Daniels BK, Shepard JW Jr. Fast-computed tomography evaluation of age-related changes in upper airway structure and function in normal men. Am Rev Respir Dis. 1992 Apr; 145: (4 Pt 1)846-52.
    View PubMed
  123. Srivatsa SS, Burger CD, Douglas WW. Upper lobe pulmonary parenchymal calcification in a patient with AIDS and Pneumocystis carinii pneumonia receiving aerosolized pentamidine. Chest. 1992 Jan; 101 (1):266-7
    View PubMed
  124. Burger CD, Hyatt RE, Staats BA. Pulmonary mechanics in lymphangioleiomyomatosis. Am Rev Respir Dis. 1991 May; 143 (5 Pt 1):1030-3
    View PubMed
  125. Shepard JW Jr, Burger CD. Nasal and oral flow-volume loops in normal subjects and patients with obstructive sleep apnea. Am Rev Respir Dis. 1990 Dec; 142(PART 1 OF 2 PARTS):1288-1293.
    View PubMed